INS and fatty liver disease: GL is a heterogeneous congenital disease (CGL) or acquired disease (AGL) characterized by loss of adipose tissue and increased insulin resistance, and an increased predisposition to metabolic complications, such as DM, hypertriglyceridemia, and hepatic steatosis (54).